Acorda Therapeutics Overview

  • Founded
  • 1995
Founded
  • Status
  • Public
  • Employees
  • 168
Employees
  • Stock Symbol
  • ACOR
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $4.21
  • (As of Monday Closing)

Acorda Therapeutics General Information

Description

Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 420 Saw Mill River Road
  • Ardsley, NY 10502
  • United States
+1 (914) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Acorda Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.21 $4.19 $2.53 - $9.84 $40M 9.5M 349K -$12.32

Acorda Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 232,280 232,280 228,400 621,470
Revenue 152,967 152,967 192,408 471,433
EBITDA (36,611) (36,611) (221,973) 49,981
Net Income (99,594) (99,594) (272,966) 33,682
Total Assets 632,680 632,680 799,718 1,299,666
Total Debt 268,564 268,564 252,825 362,137
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Acorda Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Acorda Therapeutics‘s full profile, request access.

Request a free trial

Acorda Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve
Therapeutic Devices
Ardsley, NY
168 As of 2020
00000
000000000 - 00000

00000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
00000000000 0000000
Haifa, Israel
000 As of 0000
00000
000000000 00000

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
000000000000000
Bad Homburg, Germany
0000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acorda Therapeutics Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pluristem Therapeutics Corporation Haifa, Israel 000 00000 000000000 00000
000000000 0000 Corporate Backed or Acquired Bad Homburg, Germany 0000
0000000 0000000000 Formerly PE-Backed Cambridge, MA 000 00000 000000000
00000000000 Formerly VC-backed Malvern, PA 000 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
You’re viewing 5 of 27 competitors. Get the full list »

Acorda Therapeutics Executive Team (16)

Name Title Board Seat Contact Info
Ron Cohen MD Founder, President, Board Member & Chief Executive Officer
David Lawrence Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Burkhard Blank MD Chief Medical Officer & Executive
Lauren Sabella Executive
Denise Duca Executive Vice President, Human Resources
You’re viewing 5 of 16 executive team members. Get the full list »

Acorda Therapeutics Board Members (9)

Name Representing Role Since
Barry Greene Self Board Member 000 0000
John Kelley Acorda Therapeutics Chairman & Board Member 000 0000
Lorin Randall Acorda Therapeutics Board Member 000 0000
Peder Jensen MD Acorda Therapeutics Board Member 000 0000
Ron Cohen MD Acorda Therapeutics Founder, President, Board Member & Chief Executive Officer 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Acorda Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acorda Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Acorda Therapeutics‘s full profile, request access.

Request a free trial

Acorda Therapeutics Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000000 18-Apr-2016 000000000000000000 00000 Biotechnology 000 00000 00
0000000 0000000000 23-Oct-2014 000000000000000000 00000 Drug Delivery 000 00000 00
000000000 10-Jul-2013 000000000000000000 000.00 Pharmaceuticals
0000000 09-Jul-2013 000000000000000000 Biotechnology 000 00000 00
Neuronex 21-Dec-2012 Merger/Acquisition 000.00 Pharmaceuticals
You’re viewing 5 of 7 acquisitions. Get the full list »

Acorda Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
0000000 Biotechnology Ardsley, NY
To view Acorda Therapeutics’s complete subsidiaries history, request access »